Arcadia Biosciences (RKDA)
In a report released today, Ben Klieve from National Securities Corp reiterated a Buy rating on Arcadia Biosciences, with a price target of $8.00. The company’s shares closed last Friday at $2.53, close to its 52-week low of $2.30.
According to TipRanks.com, Klieve is ranked #642 out of 7170 analysts.
Currently, the analyst consensus on Arcadia Biosciences is a Moderate Buy with an average price target of $9.00.
In a report released today, Hassan Ahmed from Alembic Global maintained a Buy rating on Trinseo, with a price target of $60.00. The company’s shares closed last Friday at $47.65, close to its 52-week high of $48.45.
According to TipRanks.com, Ahmed is a 3-star analyst with an average return of 1.7% and a 47.5% success rate. Ahmed covers the Basic Materials sector, focusing on stocks such as Westlake Chemical, Venator Materials, and Chemours Company.
Trinseo has an analyst consensus of Hold, with a price target consensus of $41.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.